GB0901898D0 - Dual calpain-ros inhibitors - Google Patents

Info

Publication number: GB0901898D0
Authority: GB; United Kingdom
Prior art keywords: calpain; dual; ros inhibitors; ros; inhibitors
Prior art date: 2009-02-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Summit Therapeutics Ltd

Original Assignee

Summit Corp PLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-06

Filing date

2009-02-06

Publication date

2009-03-11

2009-02-06Application filed by Summit Corp PLCfiledCriticalSummit Corp PLC

2009-02-06Priority to GB0901898ApriorityCriticalpatent/GB2467561A/en

2009-03-11Publication of GB0901898D0publicationCriticalpatent/GB0901898D0/en

2010-08-11Publication of GB2467561ApublicationCriticalpatent/GB2467561A/en

StatusWithdrawnlegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GB0901898A2009-02-062009-02-06Dual calpain-ROS inhibitorsWithdrawnGB2467561A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GB0901898AGB2467561A (en)	2009-02-06	2009-02-06	Dual calpain-ROS inhibitors

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0901898AGB2467561A (en)	2009-02-06	2009-02-06	Dual calpain-ROS inhibitors

Publications (2)

Publication Number	Publication Date
GB0901898D0true GB0901898D0 (en)	2009-03-11
GB2467561A GB2467561A (en)	2010-08-11

Family

ID=40469635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0901898AWithdrawnGB2467561A (en)	2009-02-06	2009-02-06	Dual calpain-ROS inhibitors

Country Status (1)

Country	Link
GB (1)	GB2467561A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012164234A1 (en)*	2011-05-27	2012-12-06	Md Pharma Ab	Novel treatments
TW201329025A (en)	2011-11-01	2013-07-16	Astex Therapeutics Ltd	Pharmaceutical compound
CN103214391B (en)*	2013-05-11	2015-08-12	罗梅	A kind of chipal compounds
EP3426674A4 (en)	2016-03-09	2019-08-14	Blade Therapeutics, Inc.	CYCLIC CE-AMIDE COMPOUNDS AS MODULATORS OF CALPAIN, AND METHODS OF MAKING AND USING SAME
WO2018009417A1 (en)	2016-07-05	2018-01-11	Blade Therapeutics, Inc.	Calpain modulators and therapeutic uses thereof
SG10201912574WA (en)	2016-09-28	2020-02-27	Blade Therapeutics Inc	Calpain modulators and therapeutic uses thereof
AU2018289434A1 (en)*	2017-06-23	2020-01-16	Blade Therapeutics, Inc.	Calpain modulators and therapeutic uses thereof
US20220257570A1 (en)*	2019-07-31	2022-08-18	Blade Therapeutics, Inc.	Calpain inhibitors and uses thereof for treating neurological disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0925786A4 (en)*	1996-07-10	2000-08-16	Mitsubishi Chem Corp	ISCHEMIC DISEASE TREATMENT AGENTS
RU2260009C2 (en)*	1999-11-05	2005-09-10	Сосьете Де Консей Де Решерш Э Д'Аппликасьон Сьентифик (С.К.Р.А.С.)	New heterocyclic compounds as pharmaceuticals
FR2863268B1 (en)*	2003-12-09	2006-02-24	Sod Conseils Rech Applic	NOVEL DERIVATIVES OF 2-HYDROXYTETRAHYDROFURAN AND THEIR APPLICATION AS MEDICAMENTS
CA2560988A1 (en)*	2004-03-29	2005-10-06	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.)	Use of a phenothiazine derivative for preventing and/or treating hearing loss
CA2626591A1 (en)*	2005-10-21	2007-04-26	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.)	Amidine derivatives and their uses as medicine

2009
- 2009-02-06GBGB0901898Apatent/GB2467561A/ennot_activeWithdrawn

Also Published As

Publication number	Publication date
GB2467561A (en)	2010-08-11

Publication	Publication Date	Title
DK3023438T3 (en)	2020-05-11	Anti-gitr-antistoffer
DK2457337T3 (en)	2020-12-07	Specialtilpasset impuls-burst
ZA201204246B (en)	2013-09-25	Kinase inhibitors
ZA201203842B (en)	2013-01-30	Kinase inhibitors
DK2442650T4 (en)	2025-08-18	Sublingualt apomorfin
EP2462514A4 (en)	2013-05-01	Greenbooks
EP2515891A4 (en)	2013-06-05	3-keto-n-propargyl-1-aminoindan
ZA201108858B (en)	2012-08-29	Iap inhibitors
EP2519921A4 (en)	2014-03-26	Call-tracking
DK2464943T3 (en)	2020-07-13	Systemintegration
GB0901898D0 (en)	2009-03-11	Dual calpain-ros inhibitors
ZA201108709B (en)	2012-08-29	Iap inhibitors
EP2496230A4 (en)	2013-05-15	Ire-1 alpha inhibitors
ZA201102837B (en)	2011-12-28	Phosphodiestarase inhibitors
GB0901900D0 (en)	2009-03-11	Dual calpain-ros inhibitors
ZA201200811B (en)	2012-10-31	Cathepsin c inhibitors
GB0914726D0 (en)	2009-09-30	Kinase inhibitors
EP2510125A4 (en)	2014-03-05	Hyperprimers
GB0902661D0 (en)	2009-04-01	Inhibitors
GB0903650D0 (en)	2009-04-15	Glyoalase inhibitors
GB0915927D0 (en)	2009-10-14	Novel inhibitors
GB0906919D0 (en)	2009-06-03	Inhibitor complex structure
AU4924P (en)	2014-09-22	Bonscablue Scaevola aemula
AU4240P (en)	2011-05-12	Tuckerbox xTriticosecale
AU4925P (en)	2014-09-22	Bonscawi Scaevola aemula

Legal Events

Date	Code	Title	Description
2011-06-29	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)

Movatterモバイル変換